SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-00-005041
Filing Date
2000-07-10
Accepted
2000-07-10 00:00:00
Documents
1
Period of Report
2000-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 0001.txt 4 16902
  Complete submission text file 0001005477-00-005041.txt   19102
Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 670495
SIC: 2834 Pharmaceutical Preparations

Mailing Address 375 PARK AVE NEW YORK NY 10152
Business Address 375 PARK AVE SUITE 1501 NEW YORK NY 10152 2128324366
ROSENWALD LINDSAY A MD (Reporting) CIK: 0000941841 (see all company filings)